Allez à nos transactions
TMT

Amber-Allen Publishing has sold its publishing assets to Penguin Publishing Group

Amber-Allen Publishing, home to some of the world’s most influential personal development books, most notably “The Four Agreements” by Don Miguel Ruiz and Janet Mills, has sold its publishing assets to Penguin Publishing Group. When the acquisition is complete, the Amber-Allen list will be managed by the TarcherPerigee imprint.

Amber-Allen Publishing was founded in 1990 by Janet Mills. Its catalog includes groundbreaking, timeless self-help and body, mind and spirit titles by Don Miguel Ruiz, Deepak Chopra, Donald Epstein, Jane Roberts, Gautama Chopra, Wayne Dyer and other thought leaders. These titles have resonated with millions of readers around the world, becoming cornerstones for those seeking guidance on their life journeys. “The Four Agreements” alone, published in 1997 and part of the Toltec Wisdom series, has sold more than 15 million copies in the USA and has been translated into 52 languages.

Penguin Publishing Group is the largest division of Penguin Random House, the world’s largest trade book publisher which is dedicated to its mission to ignite a universal passion for reading by creating books for everyone. The company, which employs more than 10,000 people globally, was formed on 1 July 2013 by Bertelsmann and Pearson. As of 1 April 2020, Bertelsmann is the full owner of the company. With more than 300 imprints and brands on six continents, Penguin Random House comprises adult and children’s fiction and nonfiction print and digital English-, German- and Spanish-language trade book publishing businesses in more than 20 countries worldwide. With over 16,000 new titles and more than 700 million print, audio and e-books sold annually, Penguin Random House’s publishing lists include more than 80 Nobel Prize laureates and hundreds of the world’s most widely read authors.

Oaklins DeSilva+Phillips, based in New York, served as the exclusive financial advisor to Amber-Allen Publishing on the transaction. Over the last three years, the team has closed seven book publishing deals, showcasing our deep sector expertise and reinforcing our position as the leading investment bank serving the book publishing industry.

Parties prenantes

Contacter l'équipe de la transaction

Joanna Stone

Associé
New York, États-Unis
Oaklins DeSilva+Phillips

Jack Noble

Associé
New York, États-Unis
Oaklins DeSilva+Phillips

Transactions connexes

Niscon Inc. a été acquise par SGPS ShowRig.
TMT

Niscon Inc. a été acquise par SGPS ShowRig.

Niscon Inc. a été acquise avec succès par SGPS ShowRig, un fournisseur mondial de solutions de scène, de levage et d’automatisation pour le divertissement en direct. Cette acquisition renforce l’engagement de SGPS ShowRig à repousser les limites de l’innovation dans l’industrie du divertissement. En intégrant la technologie unique de contrôle de mouvement de Niscon à son portefeuille, SGPS ShowRig renforce sa capacité à offrir des solutions de pointe, précises et innovantes.

En apprendre plus
Fairfest Media has acquired WTE Miami
Services de Soutien aux Entreprises | TMT

Fairfest Media has acquired WTE Miami

Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.

En apprendre plus
Banook, backed by Motion Equity, has acquired Fluidda
Soins de la Santé | TMT

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

En apprendre plus